India Therapeutic Discovery Services Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the India Therapeutic Discovery Services Market was valued at USD 128.0 million in 2025 and is projected to reach USD 175.36 million by 2032, growing at a CAGR of approximately 4.6% during 2026–2032.
India Therapeutic Discovery Services Market Highlights
| Report Metric | Details |
| Report Name | India Therapeutic Discovery Services Market |
| Market Size 2025 | USD 128.0 million |
| Market Size 2032 | USD 175.36 million |
| Absolute Growth 2025–2032 | USD 47.36 million |
| CAGR 2026–2032 | 4.6% |
| Peak Annual Growth | 6.7% in 2032 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Service Type, 2025 | Lead Optimization (39% share) |
| Leading Technology Used, 2025 | Genomics/Proteomics (43% share) |
| Leading Therapeutic Area, 2025 | Oncology (50% share) |
| Leading End User, 2025 | Pharma Companies (44% share) |
| Fastest-Growing Service Type | Antibody Discovery (6.7% CAGR) |
| Fastest-Growing Technology Used | AI-Based Models (7.3% CAGR) |
| Fastest-Growing Therapeutic Area | Immunology (6.4% CAGR) |
| Fastest-Growing End User | Biotech Firms (6.4% CAGR) |
| Growing Sector | Biotechnology |
| Key End Users | Pharma Companies, Biotech Firms, Drug Developers, CROs |
India Therapeutic Discovery Services Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Below, each year's estimated growth is shown next to the factor that most influenced it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 5.2 | The market experienced steady growth due to increased investments in drug discovery, particularly from domestic pharmaceutical companies. |
| 2023 | 1.9 | Growth slowed as some projects faced funding challenges amid economic uncertainties affecting research activities. |
| 2024 | 4.2 | Demand picked up with advancements in genomics and increased research activities in oncology. |
| 2025 | 2.5 | Market growth slowed again as companies adjusted to changing regulations in therapeutic discovery. |
| 2026 | 6.5 | The introduction of new funding schemes under the Atmanirbhar Bharat initiative is expected to boost growth in therapeutic discovery. |
| 2027 | 5.0 | Growth is projected to slow as competition intensifies among service providers in the CRO segment. |
| 2028 | 3.5 | Demand is expected to continue slowing as companies face challenges in regulatory approvals for new therapies. |
| 2029 | 2.6 | Growth will remain slow due to ongoing adjustments in research strategies among biotech firms. |
| 2030 | 4.7 | A resurgence in funding for oncology research is expected to spur growth in the therapeutic discovery market. |
| 2031 | 3.3 | Growth is projected to slow again as companies face challenges in scaling operations amid rising costs. |
| 2032 | 6.7 | The market is expected to peak with advancements in AI-based models driving demand for innovative therapeutic solutions. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
India Therapeutic Discovery Services Market Synopsis
The India Therapeutic Discovery Services Market involves the systematic identification and development of new therapeutic agents through advanced scientific methods. These services play a crucial role in drug development, particularly in oncology and neurology. The market is growing as over 300 biotech firms concentrate on developing new drug solutions. With the oncology drug market expected to expand at a CAGR of 15% from 2023, both domestic and international collaborations are driving demand.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Growing number of biotech firms focusing on therapeutic discovery. | Driver | High | Biotech Firms |
| Rising oncology drug market driving demand for therapeutic services. | Driver | High | Oncology |
| Investment opportunities in drug development projects under new funding schemes. | Opportunity | High | Pharma Companies |
| Emerging need for innovative solutions in neurology and infectious diseases. | Opportunity | Medium | Drug Developers |
| Challenges in regulatory approvals affecting project timelines. | Restraint | High | CROs |
| Limited funding for early-stage research projects constraining growth. | Restraint | Medium | Biotech Firms |
| Intense competition among service providers leading to pricing pressures. | Challenge | High | CROs |
| Delays in drug approval processes impacting market entry for new therapies. | Challenge | Medium | Pharma Companies |
Evaluation of Drivers in India Therapeutic Discovery Services Market (2026–2032)
Key forces behind demand, with the segment each one moves most, are listed below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increased investments in biotech firms. | Biotech Firms | Over 300 biotech firms in India are focusing on therapeutic discovery, driving demand for services. |
| Growth in the oncology drug market. | Oncology | India's oncology drug market is projected to grow at a CAGR of 15% from 2023, increasing demand for therapeutic services. |
| New funding schemes supporting drug development. | Pharma Companies | The Atmanirbhar Bharat initiative announced a funding scheme in 2023 to support drug development projects. |
| Advancements in genomics and molecular docking technologies. | Genomics/Proteomics | These technologies are essential for understanding biological processes, increasing service demand. |
| Rising collaborations between domestic and international firms. | Drug Developers | Collaborations improve research capabilities and expedite drug discovery processes. |
Expansion of the Therapeutic Discovery Services market in India is backed by rising investments in the biotech sector, which includes over 300 firms focusing on innovative solutions. The oncology drug market is set to grow at a CAGR of 15% from 2023, driving demand for these services. Collaborations between domestic and international firms are expediting drug discovery processes, while advancements in genomics and molecular docking technologies are vital for understanding biological processes. These factors collectively contribute to a dynamic market environment.
Evaluation of Restraints in India Therapeutic Discovery Services Market
The key brakes on demand, and where they bite hardest, are shown below.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory approval delays impacting project timelines. | CROs | Delays in drug approval processes can extend project timelines, affecting service demand. |
| Limited funding for early-stage research projects. | Biotech Firms | Funding constraints limit the ability of biotech firms to initiate new therapeutic discovery projects. |
| Intense competition leading to pricing pressures. | CROs | Increased competition among service providers can reduce pricing power and profitability. |
| Challenges in scaling operations for new entrants. | Pharma Companies | New entrants face difficulties in scaling operations due to established competitors. |
| Regulatory changes affecting operational strategies. | Drug Developers | Frequent changes in regulations can disrupt established operational strategies for drug developers. |
India Therapeutic Discovery Services Market Challenges
Over 300 biotech firms in India face intense competition, which compresses profit margins and limits available funding for therapeutic discovery services. Many producers struggle with technological limitations, as reliance on outdated methods can delay drug development timelines by six months. Regulatory hurdles create additional challenges, with the Drug Controller General of India typically taking an average of 12 months to approve new therapies, causing frustration for buyers who need timely access to treatments. Rising operational costs, including compliance with ISO 9001:2015 standards, can inflate expenses for producers by 20%, ultimately affecting pricing for buyers.
Trends in the India Therapeutic Discovery Services Market
The trends below show where the India Therapeutic Discovery Services Market is heading.
- Shift towards AI-Based Models in Drug Discovery: The use of AI-based models in drug discovery is increasing, particularly among biotech firms. In 2023, adoption rates rose by 25%, improving predictive analytics capabilities.
- Growing Focus on Oncology Research: Pharma companies are increasingly prioritising oncology research, with the oncology drug market projected to grow at a CAGR of 15% from 2023. This shift is driving demand for therapeutic discovery services.
- Transition to Advanced Genomics Techniques: There is a notable transition towards advanced genomics techniques in therapeutic discovery, especially in oncology. In 2023, over 40% of research projects incorporated genomics, improving drug development efficiency.
- Increased Collaboration between Domestic and International Firms: Collaboration between domestic and international firms is becoming more common, particularly in therapeutic discovery. In 2022, such partnerships increased by 25%, improving research capabilities.
Investment Opportunities in the India Therapeutic Discovery Services Market
The following opportunities in the India Therapeutic Discovery Services Market pair current demand with a clear way in.
- Joint Ventures for Drug Development: Establishing joint ventures with local biotech firms can open doors to new drug development projects. The current market, featuring over 300 biotech firms, offers substantial opportunities for collaboration.
- Investment in Oncology Therapeutics: The expanding oncology drug market, expected to reach USD 15 billion by 2025, generates demand for therapeutic services. Pharma companies are the primary buyers, seeking new solutions to strengthen their portfolios.
- Approval Pathways for New Therapies: Navigating the updated approval pathways for new therapies can provide a competitive advantage. The Drug Controller General of India oversees these processes, ensuring compliance and quicker market entry for new solutions.
- Supply of Advanced Genomics Services: The demand for advanced genomics services is increasing, particularly among drug developers. Investing in these services can satisfy the needs of firms focused on new therapeutic solutions.
Government Initiatives in the India Therapeutic Discovery Services Market
The National Biotechnology Development Strategy 2021 aims to boost the biotech sector's contribution to the economy, targeting $100 billion by 2025. This strategy supports therapeutic discovery services by promoting innovation and research funding. The Biotech-PRIDE initiative, launched by the Department of Biotechnology in 2022, encourages research and innovation in therapeutic discovery, providing grants and support for projects in this field.
The Drug Regulatory Authority of India oversees the approval process for new therapies, ensuring compliance with updated guidelines. In 2021, the agency streamlined approval processes to expedite the introduction of new drugs. The Biotechnology Industry Research Assistance Council provides funding for biotech projects, facilitating research and development in therapeutic discovery. This funding is essential for supporting new solutions in the market.
Future Insight of the India Therapeutic Discovery Services Market
Several forward-looking factors should support the therapeutic discovery services market in India in the coming years. The National Biotechnology Development Strategy aims to boost biotech innovation by 2025, which will streamline drug development processes. Increased funding from the Biotechnology Industry Research Assistance Council will enable a wider range of projects, particularly in oncology and neurology. Initiatives from the Indian Council of Medical Research will further advance research in infectious diseases, broadening the scope of therapeutic discovery.
Market Segmentation Analysis
The analysis below covers each segmentation, its leading category in 2025 and its fastest-growing category through 2032.
By Service Type – Lead Optimization Dominated, Antibody Discovery Expected to Grow Fastest
According to Vasudha, AM at 6Wresearch, in 2025, Lead Optimization led the service type split with a 39% share. Lead Optimization holds the largest share due to its critical role in improving the efficacy of drug candidates, which is essential for successful drug development. This service is particularly vital for oncology-focused firms, where the demand for effective therapies is substantial. Antibody Discovery is set to record the highest CAGR in this split, 6.7% over 2026–2032. Antibody Discovery is experiencing rapid growth as it is essential for developing therapeutic antibodies, especially in light of the increasing incidence of diseases like cancer. The surge in research funding for immunotherapies is significantly propelling this segment forward. Suppliers should concentrate on expanding their offerings in antibody discovery to address the rising demand from pharmaceutical companies.
By Technology Used – Genomics/Proteomics Dominated, AI-Based Models Expected to Grow Fastest
Genomics/Proteomics accounted for a 43% market share by technology used in 2025. Genomics/Proteomics commands the largest share as it is fundamental for understanding biological processes essential to drug discovery. This technology is widely adopted by many CROs to enhance the efficiency of therapeutic development. The quickest growth will come from AI-Based Models, forecast to expand at a CAGR of 7.3% between 2026 and 2032. AI-Based Models are witnessing rapid growth due to their increasing application in predictive analytics, which greatly improves the drug discovery process. The necessity for quicker and more accurate research outcomes is accelerating the adoption of AI technologies. Buyers will gain from suppliers who integrate AI capabilities into their therapeutic discovery services, improving research efficiency.
By Therapeutic Area – Oncology Dominated, Immunology Expected to Grow Fastest
Oncology took a 50% share of therapeutic area in 2025, more than any other category. Oncology leads the market share as it is a major therapeutic area with high research activity and substantial investment from both domestic and international stakeholders. The growing number of cancer cases in India further drives this focus on oncology research. Over 2026–2032, Immunology is expected to post the fastest growth, at a CAGR of 6.4%. Immunology is the fastest-growing area, driven by the urgent need for new immunotherapies to address various diseases, particularly with the rise of conditions requiring targeted treatments. The increasing emphasis on personalised medicine is also contributing to this growth. Suppliers should consider expanding their research capabilities in immunology to capitalise on this rapid growth.
By End User – Pharma Companies Dominated, Biotech Firms Expected to Grow Fastest
The largest end user category in 2025 was Pharma Companies, with a 44% share of total revenue. Pharma Companies dominate the market share as the primary users of therapeutic discovery services, relying heavily on these services for their drug development pipelines. Their substantial investments in research and development make them key players in this sector. Biotech Firms are projected to grow fastest, at a CAGR of 6.4% during 2026–2032. Biotech Firms are the fastest-growing end users, utilising therapeutic discovery services to develop innovative solutions in a competitive market. The rise of start-ups in the biotech space is further driving this growth. Suppliers should tailor their services to meet the specific needs of biotech firms, which are increasingly seeking advanced therapeutic discovery solutions.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- India Therapeutic Discovery Services Market Outlook
- Market Size of India Therapeutic Discovery Services Market, 2025
- Forecast of India Therapeutic Discovery Services Market, 2032
- Historical Data and Forecast of India Therapeutic Discovery Services Revenues & Volume for the Period 2022 - 2032F
- India Therapeutic Discovery Services Market Trend Evolution
- India Therapeutic Discovery Services Market Drivers and Challenges
- India Therapeutic Discovery Services Price Trends
- India Therapeutic Discovery Services Porter's Five Forces
- India Therapeutic Discovery Services Industry Life Cycle
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Service Type for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Target Identification for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Lead Optimization for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Antibody Discovery for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Peptide Screening for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Technology Used for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Genomics/Proteomics for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Molecular Docking for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Phage Display for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By AI-Based Models for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Therapeutic Area for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Oncology for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Neurology for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Immunology for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Infectious Diseases for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Pharma Companies for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Drug Developers for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By Biotech Firms for the Period 2022 - 2032F
- Historical Data and Forecast of India Therapeutic Discovery Services Market Revenues & Volume By CROs for the Period 2022 - 2032F
- India Therapeutic Discovery Services Import Export Trade Statistics
- Market Opportunity Assessment By Service Type
- Market Opportunity Assessment By Technology Used
- Market Opportunity Assessment By Therapeutic Area
- Market Opportunity Assessment By End User
- India Therapeutic Discovery Services Top Companies Market Share
- India Therapeutic Discovery Services Competitive Benchmarking By Technical and Operational Parameters
- India Therapeutic Discovery Services Company Profiles
- India Therapeutic Discovery Services Key Strategic Recommendations
Market Covered
The report offers an extensive study of the following market segments.
By Service Type
- Target Identification
- Lead Optimization
- Antibody Discovery
- Peptide Screening
By Technology Used
- Genomics/Proteomics
- Molecular Docking
- Phage Display
- AI-Based Models
By Therapeutic Area
- Oncology
- Neurology
- Immunology
- Infectious Diseases
By End User
- Pharma Companies
- Drug Developers
- Biotech Firms
- CROs
